stockrow
Friday 6 November 2026
Export TRAX’s income statement to Excel — free account
First Tracks Biotherapeutics, Inc.
TRAX Healthcare Biotechnology
- EPS
- +40.5%
- Free cash flow
- +55.9%
Quarter to September 2026, against a year earlier
47.78
2.35
+5.17%
Follow TRAX
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | 0.00% | 0.00% | — |
+3 more TTM periods Free account |
|
| 0.00% | (183.64%) | 0.00% | — | ||
ROIC |
0.00% | (14,355.96%) | 0.00% | 0.00% | |
Return on Tangible Assets |
(105.69%) | (101.08%) | (70.68%) | 0.00% | |
Free Cash Flow per Share |
(3.14) | (3.83) | 0.00 | — | |
Free Cash Flow |
(112.27) | (133.90) | (147.00) | — | |
Capital Expenditures |
(0.05) | (0.09) | (0.10) | — | |
| Other line items | |||||
Cash ROIC |
(36.61%) | (39.75%) | (27.03%) | 0.00% | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | — | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | — | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | — | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | — | |
Operating CF/Net income |
0.71 | 0.80 | 0.81 | — | |
Depreciation/Fixed assets |
0.96 | (0.98) | (2.10) | 0.00 | |
Capex/Depreciation |
(0.06) | 0.09 | 0.04 | — | |
Revenue per Share |
0.00 | 0.00 | — | — | |
Operating CF per Share |
(3.14) | (3.82) | 0.00 | — | |
Capex per Share |
0.00 | 0.00 | 0.00 | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | — |
Columns are period end dates · fundamentals updated 5 Nov 2026